603 related articles for article (PubMed ID: 18028460)
1. The immune system in healthy adults and patients with atopic dermatitis seems to be affected differently by a probiotic intervention.
Roessler A; Friedrich U; Vogelsang H; Bauer A; Kaatz M; Hipler UC; Schmidt I; Jahreis G
Clin Exp Allergy; 2008 Jan; 38(1):93-102. PubMed ID: 18028460
[TBL] [Abstract][Full Text] [Related]
2. Lactobacillus acidophilus 74-2 and Bifidobacterium animalis subsp lactis DGCC 420 modulate unspecific cellular immune response in healthy adults.
Klein A; Friedrich U; Vogelsang H; Jahreis G
Eur J Clin Nutr; 2008 May; 62(5):584-93. PubMed ID: 17440520
[TBL] [Abstract][Full Text] [Related]
3. The effect of probiotics on faecal microbiota and genotoxic activity of faecal water in patients with atopic dermatitis: a randomized, placebo-controlled study.
Roessler A; Forssten SD; Glei M; Ouwehand AC; Jahreis G
Clin Nutr; 2012 Feb; 31(1):22-9. PubMed ID: 21963389
[TBL] [Abstract][Full Text] [Related]
4. Dose-response study of probiotic bacteria Bifidobacterium animalis subsp lactis BB-12 and Lactobacillus paracasei subsp paracasei CRL-341 in healthy young adults.
Larsen CN; Nielsen S; Kaestel P; Brockmann E; Bennedsen M; Christensen HR; Eskesen DC; Jacobsen BL; Michaelsen KF
Eur J Clin Nutr; 2006 Nov; 60(11):1284-93. PubMed ID: 16721394
[TBL] [Abstract][Full Text] [Related]
5. Probiotic supplement reduces atopic dermatitis in preschool children: a randomized, double-blind, placebo-controlled, clinical trial.
Gerasimov SV; Vasjuta VV; Myhovych OO; Bondarchuk LI
Am J Clin Dermatol; 2010; 11(5):351-61. PubMed ID: 20642296
[TBL] [Abstract][Full Text] [Related]
6. FOXP3 mRNA expression at 6 months of age is higher in infants who develop atopic dermatitis, but is not affected by giving probiotics from birth.
Taylor AL; Hale J; Hales BJ; Dunstan JA; Thomas WR; Prescott SL
Pediatr Allergy Immunol; 2007 Feb; 18(1):10-9. PubMed ID: 17295794
[TBL] [Abstract][Full Text] [Related]
7. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial.
Taylor AL; Dunstan JA; Prescott SL
J Allergy Clin Immunol; 2007 Jan; 119(1):184-91. PubMed ID: 17208600
[TBL] [Abstract][Full Text] [Related]
8. Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: a double-blind, randomized, placebo-controlled trial.
Kim JY; Kwon JH; Ahn SH; Lee SI; Han YS; Choi YO; Lee SY; Ahn KM; Ji GE
Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 2):e386-93. PubMed ID: 19840300
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the immune benefits of two probiotic strains Bifidobacterium animalis ssp. lactis, BB-12® and Lactobacillus paracasei ssp. paracasei, L. casei 431® in an influenza vaccination model: a randomised, double-blind, placebo-controlled study.
Rizzardini G; Eskesen D; Calder PC; Capetti A; Jespersen L; Clerici M
Br J Nutr; 2012 Mar; 107(6):876-84. PubMed ID: 21899798
[TBL] [Abstract][Full Text] [Related]
10. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial.
de Vrese M; Winkler P; Rautenberg P; Harder T; Noah C; Laue C; Ott S; Hampe J; Schreiber S; Heller K; Schrezenmeir J
Clin Nutr; 2005 Aug; 24(4):481-91. PubMed ID: 16054520
[TBL] [Abstract][Full Text] [Related]
11. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial.
Viljanen M; Savilahti E; Haahtela T; Juntunen-Backman K; Korpela R; Poussa T; Tuure T; Kuitunen M
Allergy; 2005 Apr; 60(4):494-500. PubMed ID: 15727582
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulating potential of supplementation with probiotics: a dose-response study in healthy young adults.
Christensen HR; Larsen CN; Kaestel P; Rosholm LB; Sternberg C; Michaelsen KF; Frøkiaer H
FEMS Immunol Med Microbiol; 2006 Aug; 47(3):380-90. PubMed ID: 16872374
[TBL] [Abstract][Full Text] [Related]
13. Effects of probiotics on atopic dermatitis: a randomised controlled trial.
Weston S; Halbert A; Richmond P; Prescott SL
Arch Dis Child; 2005 Sep; 90(9):892-7. PubMed ID: 15863468
[TBL] [Abstract][Full Text] [Related]
14. Oral administration of two probiotic strains, Lactobacillus gasseri CECT5714 and Lactobacillus coryniformis CECT5711, enhances the intestinal function of healthy adults.
Olivares M; Díaz-Ropero MA; Gómez N; Lara-Villoslada F; Sierra S; Maldonado JA; Martín R; López-Huertas E; Rodríguez JM; Xaus J
Int J Food Microbiol; 2006 Mar; 107(2):104-11. PubMed ID: 16271414
[TBL] [Abstract][Full Text] [Related]
15. Predominant genera of fecal microbiota in children with atopic dermatitis are not altered by intake of probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium animalis subsp. lactis Bi-07.
Larsen N; Vogensen FK; Gøbel R; Michaelsen KF; Abu Al-Soud W; Sørensen SJ; Hansen LH; Jakobsen M
FEMS Microbiol Ecol; 2011 Mar; 75(3):482-96. PubMed ID: 21204871
[TBL] [Abstract][Full Text] [Related]
16. Impact of consumption of different levels of Bifidobacterium lactis HN019 on the intestinal microflora of elderly human subjects.
Ahmed M; Prasad J; Gill H; Stevenson L; Gopal P
J Nutr Health Aging; 2007; 11(1):26-31. PubMed ID: 17315077
[TBL] [Abstract][Full Text] [Related]
17. Tolerance and safety of Lactobacillus paracasei ssp. paracasei in combination with Bifidobacterium animalis ssp. lactis in a prebiotic-containing infant formula: a randomised controlled trial.
Vlieger AM; Robroch A; van Buuren S; Kiers J; Rijkers G; Benninga MA; te Biesebeke R
Br J Nutr; 2009 Sep; 102(6):869-75. PubMed ID: 19331702
[TBL] [Abstract][Full Text] [Related]
18. Tetracycline susceptibility of the ingested Lactobacillus acidophilus LaCH-5 and Bifidobacterium animalis subsp. lactis Bb-12 strains during antibiotic/probiotic intervention.
Saarela M; Maukonen J; von Wright A; Vilpponen-Salmela T; Patterson AJ; Scott KP; Hämynen H; Mättö J
Int J Antimicrob Agents; 2007 Mar; 29(3):271-80. PubMed ID: 17207972
[TBL] [Abstract][Full Text] [Related]
19. Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation.
Kopp MV; Hennemuth I; Heinzmann A; Urbanek R
Pediatrics; 2008 Apr; 121(4):e850-6. PubMed ID: 18332075
[TBL] [Abstract][Full Text] [Related]
20. LKM512 yogurt consumption improves the intestinal environment and induces the T-helper type 1 cytokine in adult patients with intractable atopic dermatitis.
Matsumoto M; Aranami A; Ishige A; Watanabe K; Benno Y
Clin Exp Allergy; 2007 Mar; 37(3):358-70. PubMed ID: 17359386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
